Edwards Lifesciences Corporation Share Price
Stocks
EW
US28176E1082
Advanced Medical Equipment & Technology
|
Market Closed -
NYSE
21:00:03 04/11/2026 GMT
|
5-day change | 1st Jan Change | ||
| 99.37 USD | +4.39% |
|
+8.27% | +16.56% |
| 10:53am | UBS Adjusts Price Target on Edwards Lifesciences to $118 From $110 | MT |
| 10:46am | UBS Adjusts Price Target on Edwards Lifesciences to $118 From $110 | MT |
| Market Cap | 57.28B 51.04B 46.81B 42.54B 79.96B 5,413B 81.79B 559B 224B 2,865B 215B 210B 9,076B | P/E 2026 * |
39.4x | P/E 2027 * | 30.2x |
|---|---|---|---|---|---|
| Enterprise Value | 53.65B 47.8B 43.84B 39.84B 74.9B 5,070B 76.61B 524B 210B 2,683B 201B 197B 8,500B | EV / Sales 2026 * |
7.93x | EV / Sales 2027 * | 7.01x |
| Free-Float |
86.96% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| EW | Delayed | |
CBOE
| EW | Real-time | |
|
Tradegate
| EWL | Real-time | |
|
Xetra
| EWL | Delayed | |
|
Boerse Muenchen
| EWL | Real-time | |
|
Mexican S.E.
| EW * | End-of-day quote | |
|
Deutsche Boerse AG
| EWL | Delayed | |
|
Börse Stuttgart
| EWL | Delayed | |
|
Wiener Boerse
| EWLS | End-of-day quote | |
|
Borsa Italiana
| 1EW | End-of-day quote | |
|
Swiss Exchange
| EW | Delayed | |
|
Swiss Exchange
| EW | Delayed | |
|
CBOE
| 0REN | Real-time | |
|
CBOE
| Real-time |
Last Transcript: Edwards Lifesciences Corporation
| 1 day | +4.39% | ||
| 1 week | +8.27% | ||
| Current month | +8.00% | ||
| 1 month | +16.70% | ||
| 3 months | +10.90% | ||
| 6 months | +19.25% | ||
| Current year | +16.56% |
| 1 week | 87.9 |  | 100.25 |
| 1 month | 82.42 | | 100.25 |
| Current year | 74.66 | | 100.25 |
| 1 year | 74.66 | | 100.25 |
| 3 years | 58.93 | | 100.25 |
| 5 years | 58.93 | | 131.73 |
| 10 years | 27.04 | | 131.73 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 58 | 10/05/2023 | |
Theodora Mistras
DFI | Director of Finance/CFO | 43 | 28/05/2026 |
| Chief Tech/Sci/R&D Officer | 51 | 31/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | 06/05/2024 | |
Kieran Gallahue
BRD | Director/Board Member | 62 | 09/02/2015 |
| Director/Board Member | 58 | 10/05/2023 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 08/10/26 | Exercice | Executive/Senior Manager | 1,857 | 0.0003% | ||
| 14/09/26 | Tax | Executive/Senior Manager | -568 | 0.0001% | ||
| 13/09/26 | Tax | Controller/Auditor | -253 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +4.39% | +8.27% | +18.09% | +48.16% | 57.28B | |
| +1.12% | +0.29% | +24.93% | +55.29% | 262B | |
| +2.09% | +0.37% | +9.87% | +18.73% | 165B | |
| +9.38% | +8.54% | -10.53% | +73.09% | 167B | |
| +5.33% | +7.99% | -53.64% | -12.77% | 66.41B | |
| -2.14% | +1.82% | -2.96% | -8.20% | 56.02B | |
| +0.97% | -2.37% | +21.28% | +62.51% | 49.95B | |
| +2.45% | -2.26% | +5.84% | +59.63% | 50.29B | |
| +1.67% | -1.95% | +27.29% | +79.51% | 45.94B | |
| +6.38% | +13.18% | +15.49% | +19.90% | 38.8B | |
| Average | +1.53% | +3.27% | +5.57% | +39.58% | 95.87B | |
| Weighted average by Cap. | +0.78% | +2.78% | +7.21% | +43.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.76B 6.02B 5.53B 5.02B 9.44B 639B 9.65B 66.04B 26.47B 338B 25.38B 24.83B 1,071B | 7.43B 6.62B 6.07B 5.52B 10.38B 702B 10.61B 72.59B 29.1B 372B 27.9B 27.3B 1,178B |
| Net income | 1.46B 1.3B 1.19B 1.08B 2.04B 138B 2.08B 14.24B 5.71B 72.95B 5.47B 5.36B 231B | 1.88B 1.68B 1.54B 1.4B 2.63B 178B 2.69B 18.38B 7.37B 94.14B 7.06B 6.91B 298B |
| Net Debt | -3.63B -3.24B -2.97B -2.7B -5.07B -343B -5.18B -35.46B -14.22B -182B -13.63B -13.34B -575B | -5.19B -4.63B -4.25B -3.86B -7.25B -491B -7.42B -50.74B -20.34B -260B -19.5B -19.08B -823B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 04/11/26 | US$99.37 | +4.39% | 7,897,496 |
| 03/11/26 | US$95.19 | +2.07% | 6,559,254 |
| 02/11/26 | US$93.26 | +1.36% | 12,172,521 |
| 30/10/26 | US$92.01 | -2.57% | 6,044,702 |
| 29/10/26 | US$94.44 | +2.90% | 4,680,786 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EW Stock
Select your edition
All financial news and data tailored to specific country editions
